Mark D. Schwinden

Statistics

Publications

Citations

341

H-Index

Active since

1990

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Mark D. Schwinden is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and synthetic medicinal chemistry.

Publications per year

1990–2009

Publications

Enzymatic synthesis of l-6-hydroxynorleucine

Ronald L. Hanson, Mark D. Schwinden, Amit Banerjee et al. · Bioorganic & Medicinal Chemistry · 1999 · 88 citations

Life Sciences, Biochemistry, Enzymology +3

One-Carbon Chain Extension of Esters to α-Chloroketones: A Safer Route without Diazomethane

Dengjin Wang, Mark D. Schwinden, Lilian Radesca et al. · The Journal of Organic Chemistry · 2004 · 71 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632

Zhongmin Xu, Janak Singh, Mark D. Schwinden et al. · Organic Process Research & Development · 2002 · 63 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

Process Research and Development for a Tetrazole-Based Growth Hormone Secretagogue (GHS) Pharmaceutical Development Candidate

Akin H. Davulcu, Douglas D. McLeod, Jun Li et al. · The Journal of Organic Chemistry · 2009 · 36 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery of a Tetrazole-Based Growth Hormone Secretagogue: 4-(Hydroxybutyl)carbamic Acid 2-{5-[1-(2-Amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl Ester (BMS-317180)

Jun Li, Stephanie Chen, James J. Li et al. · Journal of Medicinal Chemistry · 2007 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 7